Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SERPINE1 mRNA Binding Protein 1 (SERBP1) Peptide

SERBP1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN983556

Quick Overview for SERPINE1 mRNA Binding Protein 1 (SERBP1) Peptide (ABIN983556)

Target

SERBP1 (SERPINE1 mRNA Binding Protein 1 (SERBP1))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-SERBP1 antibody (Catalog #: ARP40310_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    SERBP1 (SERPINE1 mRNA Binding Protein 1 (SERBP1))

    Background

    SERBP1 may play a role in the regulation of mRNA stability. It binds to the 3'-most 134 nt of the SERPINE1/PAI1 mRNA, a region which confers cyclic nucleotide regulation of message decay.

    Alias Symbols: CGI-55, CHD3IP, DKFZp564M2423, FLJ90489, HABP4L, PAI-RBP1, PAIRBP1

    Protein Interaction Partner: CHD3,CHD3,DAXX,FXYD3,PIAS1,PIAS3,PIAS4,TDG,TOPORS,UBA2,VIM,CHD3,FXYD3,VIM

    Protein Size: 408

    Molecular Weight

    45 kDa

    Gene ID

    26135

    NCBI Accession

    NM_001018067, NP_001018077

    UniProt

    Q8NC51
You are here:
Chat with us!